Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cary Fu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
BMJ Paediatrics Open|October 7, 2020
Multisystem comorbidities in classic Rett syndrome: a scoping reviewCary Fu, Dallas Armstrong, Eric Marsh, et al.
Genes|August 29, 2024
Clinical Features and Disease Progression in Older Individuals with Rett SyndromeJeffrey L Neul, Timothy A Benke, Eric D Marsh, et al.
BMJ Paediatrics Open|September 28, 2020
Consensus guidelines on managing Rett syndrome across the lifespanCary Fu, Dallas Armstrong, Eric Marsh, et al.
American Journal of Medical Genetics. Part A|November 10, 2020
Phenotypic features in MECP2 duplication syndrome: Effects of ageSarika U Peters, Cary Fu, Eric D Marsh, et al.
American Journal on Intellectual and Developmental Disabilities|November 19, 2020
A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical TrialsMelissa Raspa, Carla M Bann, Angela Gwaltney, et al.
Clinical Genetics|February 22, 2019
Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndromeSarika U Peters, Cary Fu, Bernhard Suter, et al.
Med (New York, N.Y.)|March 5, 2025
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndromeAlan K Percy, Robin Ryther, Eric D Marsh, et al.
Journal of Neurodevelopmental Disorders|September 17, 2021
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorderHeather E Olson, Carolyn I Daniels, Isabel Haviland, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Medical Genetics. Part A|June 14, 2025
Medical Biases and Misconceptions Impact Diagnoses in Males With Loss of Function MECP2 VariantsTalia Thompson, Dennis Gurfinkel, Lori Silveira, et al.
Journal of Neurodevelopmental Disorders|January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndromeKathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
BMJ Paediatrics Open|October 7, 2020
Multisystem comorbidities in classic Rett syndrome: a scoping reviewCary Fu, Dallas Armstrong, Eric Marsh, et al.
Genes|August 29, 2024
Clinical Features and Disease Progression in Older Individuals with Rett SyndromeJeffrey L Neul, Timothy A Benke, Eric D Marsh, et al.
BMJ Paediatrics Open|September 28, 2020
Consensus guidelines on managing Rett syndrome across the lifespanCary Fu, Dallas Armstrong, Eric Marsh, et al.
American Journal of Medical Genetics. Part A|November 10, 2020
Phenotypic features in MECP2 duplication syndrome: Effects of ageSarika U Peters, Cary Fu, Eric D Marsh, et al.
American Journal on Intellectual and Developmental Disabilities|November 19, 2020
A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical TrialsMelissa Raspa, Carla M Bann, Angela Gwaltney, et al.
Clinical Genetics|February 22, 2019
Characterizing the phenotypic effect of Xq28 duplication size in MECP2 duplication syndromeSarika U Peters, Cary Fu, Bernhard Suter, et al.
Med (New York, N.Y.)|March 5, 2025
Results from the phase 2/3 DAFFODIL study of trofinetide in girls aged 2-4 years with Rett syndromeAlan K Percy, Robin Ryther, Eric D Marsh, et al.
Journal of Neurodevelopmental Disorders|September 17, 2021
Current neurologic treatment and emerging therapies in CDKL5 deficiency disorderHeather E Olson, Carolyn I Daniels, Isabel Haviland, et al.
Pageof 4